300791 Stock Overview
Operates as a contract manufacturer for dietary supplement industry worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Sirio Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥24.49 |
| 52 Week High | CN¥33.37 |
| 52 Week Low | CN¥18.65 |
| Beta | 0.73 |
| 11 Month Change | 11.32% |
| 3 Month Change | -17.20% |
| 1 Year Change | 22.73% |
| 33 Year Change | -32.97% |
| 5 Year Change | n/a |
| Change since IPO | -9.11% |
Recent News & Updates
Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01
Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Recent updates
Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Is Sirio Pharma (SZSE:300791) A Risky Investment?
Jun 12An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued
Apr 24Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Mar 06Shareholder Returns
| 300791 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 7.6% | 3.6% | 1.2% |
| 1Y | 22.7% | -36.7% | -20.3% |
Return vs Industry: 300791 exceeded the CN Personal Products industry which returned -36.7% over the past year.
Return vs Market: 300791 exceeded the CN Market which returned -20.3% over the past year.
Price Volatility
| 300791 volatility | |
|---|---|
| 300791 Average Weekly Movement | 5.0% |
| Personal Products Industry Average Movement | 4.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.8% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300791's share price has been volatile over the past 3 months.
Volatility Over Time: 300791's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,610 | Peiqing Li | www.siriopharma.com |
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging.
Sirio Pharma Co., Ltd. Fundamentals Summary
| 300791 fundamental statistics | |
|---|---|
| Market cap | CN¥5.74b |
| Earnings (TTM) | CN¥334.33m |
| Revenue (TTM) | CN¥4.03b |
17.2x
P/E Ratio1.4x
P/S RatioIs 300791 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300791 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.03b |
| Cost of Revenue | CN¥2.77b |
| Gross Profit | CN¥1.26b |
| Other Expenses | CN¥922.70m |
| Earnings | CN¥334.33m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 31.21% |
| Net Profit Margin | 8.30% |
| Debt/Equity Ratio | 47.2% |
How did 300791 perform over the long term?
See historical performance and comparison